RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jianying Zhang to Female

This is a "connection" page, showing publications Jianying Zhang has written about Female.
Connection Strength

0.386
  1. Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer. 2016 09; 99:172-9.
    View in: PubMed
    Score: 0.036
  2. Li Y, Francia G, Zhang JY. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer. Oncotarget. 2015 Oct 20; 6(32):32656-68.
    View in: PubMed
    Score: 0.034
  3. Zhou JW, Li Y, Yue LX, Luo CL, Chen Y, Zhang JY. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma. Tumour Biol. 2016 Feb; 37(2):2547-53.
    View in: PubMed
    Score: 0.034
  4. Liu Y, Dai L, Liu W, Shi G, Zhang J. Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus. J Immunol Res. 2015; 2015:963568.
    View in: PubMed
    Score: 0.033
  5. Zhu Q, Han SX, Zhou CY, Cai MJ, Dai LP, Zhang JY. Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget. 2015 May 10; 6(13):11575-84.
    View in: PubMed
    Score: 0.033
  6. Liu X, Peng B, Li Y, Lei N, Li W, Zhang JY. p90/CIP2A mediates breast cancer cell proliferation and apoptosis. Mol Biol Rep. 2014 Nov; 41(11):7471-8.
    View in: PubMed
    Score: 0.031
  7. Liu M, Zheng SJ, Chen Y, Li N, Ren PF, Dai LP, Duan ZP, Zhang JY. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma. J Immunol Res. 2014; 2014:906532.
    View in: PubMed
    Score: 0.031
  8. Liu X, Ye H, Li L, Li W, Zhang Y, Zhang JY. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. J Immunol Res. 2014; 2014:326593.
    View in: PubMed
    Score: 0.031
  9. Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol. 2014 May-Jun; 152(1-2):127-39.
    View in: PubMed
    Score: 0.030
  10. Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett. 2010 Mar 01; 289(1):32-9.
    View in: PubMed
    Score: 0.022
  11. Chen Y, Lin P, Qiu S, Peng XX, Looi K, Farquhar MG, Zhang JY. Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. Int J Oncol. 2007 May; 30(5):1137-44.
    View in: PubMed
    Score: 0.019
  12. Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol. 2007 Jan; 46(1):107-14.
    View in: PubMed
    Score: 0.018
  13. Sun W, Tseng TB, Zhang J, Qian W. Enhancing deep convolutional neural network scheme for breast cancer diagnosis with unlabeled data. Comput Med Imaging Graph. 2017 04; 57:4-9.
    View in: PubMed
    Score: 0.009
  14. Sun W, Tseng TL, Zhang J, Qian W. Computerized breast cancer analysis system using three stage semi-supervised learning method. Comput Methods Programs Biomed. 2016 Oct; 135:77-88.
    View in: PubMed
    Score: 0.009
  15. Luo CL, Liu YQ, Wang P, Song CH, Wang KJ, Dai LP, Zhang JY, Ye H. The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomed Pharmacother. 2016 Aug; 82:595-605.
    View in: PubMed
    Score: 0.009
  16. Sun W, Tseng TL, Qian W, Zhang J, Saltzstein EC, Zheng B, Lure F, Yu H, Zhou S. Using multiscale texture and density features for near-term breast cancer risk analysis. Med Phys. 2015 Jun; 42(6):2853-62.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support